« Previous
Next »
American Journal of Kidney Diseases
Volume 41
, Pages 3-10
, June 2003
Meeting the challenges of the new K/DOQI guidelines
References
- . History of the science of dialysis. Am J Nephrol. 1997;17:289–298
- . The early years of chronic dialysis (The Seattle contribution). Am J Nephrol. 1999;19:350–354
- . Excerpts from the US Renal Data System 2000 Annual Data Report (Atlas of End-Stage Renal Disease in the United States). Am J Kidney Dis. 2000;36(suppl 2):S1–S239
-
.
K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease (Executive Summary). New York, NY: National Kidney Foundation; 2002;
- Left ventricular mass index increase in early renal disease (Impact of decline in hemoglobin). Am J Kidney Dis. 1999;34:125–134
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–192
-
Prognostic value of serum creatinine and effect of treatment of hypertension on renal function (Results from the Hypertension Detection and Follow-Up Program).
Hypertension. 1989;13(suppl I):SI80–SI93
- Proteinuria is a risk factor for mortality over 10 years of follow-up. Kidney Int Suppl. 1997;63:S10–S14
- . Chronic renal confusion (Insufficiency, failure, dysfunction, or disease). Am J Kidney Dis. 2000;36:415–418
- . A more accurate method to estimate glomerular filtration rate from serum creatinine (A new prediction equation). Ann Intern Med. 1999;130:461–470
- . Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
- . A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259–263
- . Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child. 1976;51:875–878
- . Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–838
- Why don’t physicians follow clinical practice guidelines? (A framework for improvement). JAMA. 1999;282:1458–1465
☆ Supported by an unrestricted educational grant from Watson Pharma, Inc.
PII: S0272-6386(03)00371-8
doi: 10.1016/S0272-6386(03)00371-8
© 2003 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 41
, Pages 3-10
, June 2003
